Home›Companies›Healthcare›Javara

Javara Inc.

Updated Oct 27, 2026·Latest SEC filing May 28, 2025·Suggest an edit

About Javara

Javara is a private company based in Winston-Salem, North Carolina. It has reported $59,691,262 raised in six offerings on Form D since August 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 13, 2025May 28, 2025$6,600,550of $10.0M target23$286KEquityRule 506(b)Form D ↗
Nov 1, 2023Nov 9, 2023$9,430,000fully sold5$1.8MDebtRule 506(b)Form D ↗
Apr 1, 2022Apr 12, 2022$30,000,003of $47.5M target2$15.0MEquityRule 506(b)Form D ↗
Aug 23, 2021Sep 1, 2021$5,285,109of $7.0M target12$440KEquityRule 506(b)Form D ↗
Aug 10, 2020Aug 19, 2020$4,600,000fully sold11$418KEquityRule 506(b)Form D ↗
Aug 8, 2019Aug 13, 2019$3,775,600of $4.7M target9$419KEquityRule 506(b)Form D ↗
Total, six offerings$59,691,262

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Javara's Form D filed May 28, 2025.

JB
Jennifer Byrne
Executive officer and director
BZ
Brett Zbar
Director
LM
Linda Mccarty
Chief Legal Officer and Secretary
JK
TJ
Todd Johnson
Director
ET
Erika Taurel
Executive officer

Earlier filings also listed Thomas Pike (director, last listed Nov 2023), Joseph Von Rickenbach (director, last listed Apr 2022), Andrew Domescik (executive officer, last listed Apr 2022), John Vann (director, last listed Sep 2021), Gerald Roach (director, last listed Sep 2021), Charles Johnson (director, last listed Sep 2021) and Charles Hauser (director, last listed Sep 2021).

Sources

  1. SECJavara Inc. filing history